Biora Therapeutics, Inc. (NASDAQ:BIOR) Short Interest Update

Biora Therapeutics, Inc. (NASDAQ:BIOR) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 140,800 shares, a drop of 93.4% from the September 30th total of 2,130,000 shares. Based on an average daily volume of 30,500 shares, the days-to-cover ratio is presently 4.6 days. Approximately 4.1% of the shares of the company are short sold.

Biora Therapeutics Price Performance

BIOR stock traded up $0.55 during mid-day trading on Friday, reaching $4.05. 125,692 shares of the company’s stock were exchanged, compared to its average volume of 34,589. The stock’s 50 day moving average is $5.94 and its 200 day moving average is $6.42. Biora Therapeutics has a 12-month low of $3.38 and a 12-month high of $21.10. The company has a market cap of $14.90 million, a price-to-earnings ratio of -0.07 and a beta of 1.22.

Biora Therapeutics (NASDAQ:BIOR) last released its quarterly earnings results on Monday, August 12th. The company reported ($3.50) earnings per share for the quarter, topping the consensus estimate of ($4.50) by $1.00. The company had revenue of $0.32 million for the quarter. On average, research analysts forecast that Biora Therapeutics will post -12.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and issued a $150.00 target price on shares of Biora Therapeutics in a research note on Tuesday, August 13th.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.